hydroxychloroquine has been researched along with Uveitis in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient received induction therapy with steroids, cyclophosphamide and hydroxychloroquine followed by rapid clinical improvement and remission of proteinuria." | 3.96 | A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis. ( Boletis, JN; Liapis, G; Marinaki, S; Skalioti, C; Vallianou, K, 2020) |
| "Surgical treatment of cataracts, band keratopathy, and glaucoma achieved uniformly discouraging results." | 1.25 | Ocular manifestations of juvenile rheumatoid arthritis. ( Bellows, AR; Bienfang, DC; Chylack, LT; Stillman, JS, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y | 1 |
| Li, Z | 2 |
| Chen, G | 1 |
| Huang, J | 1 |
| Huang, H | 1 |
| Xie, Y | 1 |
| Chen, Q | 1 |
| Zhu, W | 1 |
| Wang, M | 1 |
| Chen, J | 1 |
| Su, W | 1 |
| Chen, X | 1 |
| Liang, D | 1 |
| Jensen, ME | 1 |
| Harrell, K | 1 |
| McBride, JD | 1 |
| Vallianou, K | 1 |
| Skalioti, C | 1 |
| Liapis, G | 1 |
| Boletis, JN | 1 |
| Marinaki, S | 1 |
| Chylack, LT | 1 |
| Bienfang, DC | 1 |
| Bellows, AR | 1 |
| Stillman, JS | 1 |
| Wright, V | 1 |
| Dixon, JS | 1 |
| Bird, HA | 1 |
| Henkind, P | 1 |
| Gold, DH | 1 |
| Yonemura, D | 1 |
2 reviews available for hydroxychloroquine and Uveitis
| Article | Year |
|---|---|
Ocular manifestations of rheumatic disorders. Natural and iatrogenic.
Topics: Adrenal Cortex Hormones; Arteritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Chloroquine; Conjunc | 1973 |
[Review of electroretinography: 1970].
Topics: Animals; Anura; Cats; Cyprinidae; Diabetes Mellitus; Dogs; Electrooculography; Electroretinography; | 1971 |
5 other studies available for hydroxychloroquine and Uveitis
| Article | Year |
|---|---|
Hydroxychloroquine Alleviates EAU by Inhibiting Uveitogenic T Cells and Ameliorating Retinal Vascular Endothelial Cells Dysfunction.
Topics: Animals; Cytokines; Endothelial Cells; Hydroxychloroquine; Mice; Mice, Inbred C57BL; NF-kappa B; Sca | 2022 |
Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Topics: Arthritis; Dermatitis; Granuloma; Humans; Hydroxychloroquine; Infant; Male; Methotrexate; Mutation; | 2023 |
A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis.
Topics: Aged; Antirheumatic Agents; Arthritis; Chronic Urticaria; Complement System Proteins; Cyclophosphami | 2020 |
Ocular manifestations of juvenile rheumatoid arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Arthritis, Juvenile; Atropine; Cataract; Ch | 1975 |
Therapeutic significance of laboratory results in rheumatic disease.
Topics: Anti-Inflammatory Agents; Arthritis, Reactive; Aspirin; Blood Viscosity; C-Reactive Protein; Captopr | 1985 |